Search Results - Karl Sitz, MD
- Showing 1 - 1 results of 1
-
1
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria by Martin Metz, MD, Jonathan A. Bernstein, MD, Ana M. Giménez-Arnau, MD, PhD, Michihiro Hide, MD, PhD, Marcus Maurer, MD, Karl Sitz, MD, Weily Soong, MD, Gordon Sussman, MD, Eva Hua, MSc, Avantika Barve, PhD, Nathalie Barbier, MSc, Maria-Magdalena Balp, MD, Thomas Severin, MD
Published in World Allergy Organization Journal (2022-11-01)Get full text
Article
